Mitobronitol
Appearance
Names | |
---|---|
Preferred IUPAC name
1,6-Dibromo-1,6-dideoxy-D-mannitol[citation needed] | |
Systematic IUPAC name
1,6-Dibromohexane-2,3,4,5-tetrol[1] | |
Identifiers | |
| |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.006.979 |
EC Number |
|
KEGG | |
MeSH | Mitobronitol |
PubChem CID
|
|
RTECS number |
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H12Br2O4 | |
Molar mass | 307.966 g·mol−1 |
Appearance | Colourless crystals |
log P | −0.226 (2RS,3RS,4RS,5RS)-2,3,4,5-tetrol |
Acidity (pKa) | 12.609 (2RS,3RS,4RS,5RS)-2,3,4,5-tetrol |
Basicity (pKb) | 1.388 (2RS,3RS,4RS,5RS)-2,3,4,5-tetrol |
Pharmacology | |
L01AX01 (WHO) | |
Related compounds | |
Related compounds
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Mitobronitol (1,6-dibromo-1,6-dideoxy-D-mannitol) is a brominated analog of mannitol. It is an anticancer drug that is also classified as an alkylating agent.[2]
References
[edit]- ^ "Mitolactol - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 25 March 2005. Identification. Retrieved 22 June 2012.
- ^ Mitobronitol, The Centre for Cancer Education